Latest Videos

Differentiating PSMA Diagnostics & Therapeutics

Phillip J. Koo, MD, examines radiopharmaceuticals, addressing trends and challenges in imaging and therapeutics. In this 11-minute presentation, Dr. Koo theorizes that radiology’s commoditization, accelerated by private equity and shifting toward high-volume, low-quality imaging, has raised concerns about diagnostic consistency.

Dr. Koo shares that the accessibility of PSMA PET imaging has rapidly expanded in the US. High utilization rates have led to issues of potential overuse and over-treatment, underscoring the need for more deliberate clinical decision-making. Variable imaging quality, often tied to the facility’s focus on throughput over accuracy, presents risks in diagnostics and patient outcomes. His presentation calls for ongoing advancements in both technology and professional collaboration to fully realize these tools’ therapeutic and diagnostic value.

Read More

Functional Urology Discussion

Brian J. Flynn, MD, is a professor of surgery/urology and fellowship director in Functional and Reconstructive Urology (FRU) at the University of Colorado, Anschutz Medical Center, Division of Urology, in Denver, Colorado. Dr. Flynn earned his medical degree from Temple University in Philadelphia, Pennsylvania. He completed a six-year residency in urology at Geisinger Medical Center in Danville, Pennsylvania, and a one-year fellowship in female urology and reconstructive urology at Duke University in Durham, North Carolina. He is board-certified in urology and female pelvic medicine and reconstructive surgery. Dr. Flynn earned his Bachelor of Science in biomedical engineering from the University of Rochester in Rochester, New York.

Dr. Flynn’s focus is in functional and reconstructive urology with an active
practice in male/female urinary incontinence, voiding dysfunction, urethral stricture disease, and robotic bladder/ureteral reconstructive surgery. He is a national leader in the use of minimally invasive surgical techniques and robotics for the treatment of urinary incontinence, bladder neck contracture, urethral stricture, and ureteral obstruction. He has developed new techniques for AUS, ProACT, bladder neck
reconstruction, and suprapubic catheter placement.

Dr. Flynn has authored numerous clinical papers, surgical videos, and textbook chapters. He has also presented internationally on surgical management of urethral stenosis with an emphasis on non-transecting techniques, post-prostatectomy incontinence, genitourinary fistula, and ureteral stricture disease.

Alan J. Wein, MD, PhD (hon), FACS, is Professor of Clinical Urology and Director of Business Development and Mentoring at the Desai Sethi Institute of Urology at the University of Miami Miller School of Medicine. He is Emeritus Professor of Urology/Surgery and Emeritus Chief of Urology and Program Director of the Perelman School of Medicine at the University of Pennsylvania.

Dr. Wein received his undergraduate degree from Princeton University and completed medical school, surgery, basic research, and urology training at the University of Pennsylvania (Penn). After serving in the army following his training, he returned to Penn where he ultimately became Chief of Urology and Director of the Residency Program (for 38 and 44 years, respectively). Dr. Wein holds an honorary PhD from the University of Patras, Greece and was conferred an honorary professorship by the Institute of Urology, Russian Ministry of Health.

Dr. Wein’s primary interests include the physiology and pharmacology of the lower urinary tract, evaluation and management of urinary incontinence and all types of lower urinary tract and pelvic floor dysfunction; problems with prostate enlargement and obstruction; and the evaluation and management of prostate, bladder, and kidney cancer. He has received numerous awards and honors for excellence in the field of urology and has been recognized nationally and internationally through his many affiliations and professional memberships. These include the American Association of Genitourinary Surgeons (AAGUS), the Clinical Society of Genitourinary Surgeons (CSGUS); the American Surgical Association; the Society of Surgical Oncology; the Society of Urologic Oncology (where he is a founding member); the Society of Pelvic Surgeons; Society of Urodynamics, Female Pelvic Medicine, and Urogenital Reconstruction (SUFU); the International Continence Society (ICS); Société Internationale d’Urologie (SIU); the American Urological Association (AUA); the European Association of Urology (EAU); and the Royal Society of Medicine.

Dr. Wein’s most notable awards include the Urodynamics Society Lifetime Achievement Award; the F. Brantley Scott Award of the American Foundation for Urologic Diseases; the Hugh Hampton Young Award of the AUA; the Ferdinand C. Valentine Award of the New York Academy of Medicine; the National Association for Continence Continence Care Champion Award; Lifetime Achievement Awards from SUFU, the ICS, and the SIU; the Ellis Island Medal of Honor; and the Keyes Medal by the AAGUS, which is recognized as the greatest individual citation in the specialty, awarded for outstanding contributions in the advancement of urology. Most recently, an annual mentorship award in his name has been commissioned by SUFU and another by the division of urology at Penn. Dr. Wein has authored or co-authored over 1,000 papers and book chapters, held multiple editorial positions on scientific journals and has edited or co-edited over 35 books. He is currently the editor-in-chief of Neurourology and Urodynamics and Urology Case Reports. Dr. Wein was editor-in-chief of the ninth, 10th, and 11th editions of Campbell-Walsh Urology, the gold standard textbook in the field and the name of the 12th and succeeding editions has been changed to Campbell-Walsh-Wein Urology to reflect his contributions to the field. Two chairs have been raised and named in his honor in the division of urology, department of surgery at the University of Pennsylvania Perelman School of Medicine.

Read More

Innovative Office-based Kidney Stone Treatment

Mathew Sorensen, MD, MS, FACS, Associate Professor of Urology at the University of Washington in Seattle, examines advances in non-invasive treatments for kidney stones, highlighting two key technologies poised to shift clinical practice. In this 21-minute presentation, he discusses ultrasonic propulsion and then transitions to a second innovation, burst wave lithotripsy. Clinical studies on these technologies indicate a shift toward managing smaller stones and residual fragments more proactively, potentially avoiding more invasive interventions.

Read More

Artificial Intelligence and Machine Learning in Diagnosis of Urologic Cancer – Current Trends and Future Perspectives

Priya N. Werahera, PhD emphasizes integrating artificial intelligence (AI) into clinical practice, highlighting this evolving field’s potential benefits and challenges. In this 13-minute presentation, Dr. Werahera underscores that AI must be carefully balanced with the expertise of doctors and pathologists, a crucial part of the diagnostic and decision-making processes.

Dr. Werehera discusses both Virtual AI (diagnosis, symptom management) and Physical AI (robotic surgery, nanotechnology for drug delivery). He notes the benefits of integrating AI into practice, such as precision diagnoses, individualized therapies, and cost savings. He also discusses the importance of supervised and unsupervised learning for AI models, providing a renal cancer example to illustrate different approaches using AI.

Looking towards the future, the speaker expresses optimism about AI’s potential to transform healthcare by enhancing diagnostic accuracy, improving patient outcomes, and streamlining healthcare delivery. This collaborative approach, where AI supports but does not supplant clinicians, is seen as the key to unlocking a bright future in healthcare characterized by innovation and improved quality of care.

Read More

Functional Urology: A New Sub-Specialty or Rebranding?

Brian J. Flynn, MD, focuses on defining and exploring the evolving specialties of functional and reconstructive urology, emphasizing the need for rebranding within the field. In this 11-minute talk, he stresses that functional urology, similar to specialties like female pelvic medicine and pediatric urology, deserves rebranding efforts.

Dr. Flynn advocates for collaboration between urologists and non-physicians to expand the field’s influence, particularly in addressing lower urinary tract dysfunctions. He also discusses how urologists can better integrate into the broader medical community, learning from global models, especially in Europe and Canada, where functional and integrative approaches are more advanced.

Functional urology is a comprehensive, patient-centered specialty with a broad scope of practice encompassing all lower urinary tract disorders.

Read More